Back to Search Start Over

Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease

Authors :
Scott Bingham
J. Ronald Mikolich
Dipan J. Shah
Subha V. Raman
Afshin Farzaneh-Far
Victor A. Ferrari
Bobak Heydari
Shuaib M Abdullah
Steve W. Leung
Kevin Steel
Chetan Shenoy
Jeanette Schulz-Menger
Matthias Stuber
W. Patricia Bandettini
Raymond Y. Kwong
Andrew E. Arai
John F. Heitner
Orlando P. Simonetti
Jorge A. Gonzalez
Amit R. Patel
Yin Ge
Panagiotis Antiochos
Source :
JACC: Cardiovascular Imaging. 15:60-71
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

This study sought to determine whether stress cardiac magnetic resonance (CMR) provides clinically relevant risk reclassification in patients with known coronary artery disease (CAD) in a multicenter setting in the United States.Despite improvements in medical therapy and coronary revascularization, patients with previous CAD account for a disproportionately large portion of CV events and pose a challenge for noninvasive stress testing.From the Stress Perfusion Imaging in the United States (SPINS) registry, we identified consecutive patients with documented CAD who were referred to stress CMR for evaluation of myocardial ischemia. The primary outcome was nonfatal myocardial infarction (MI) or cardiovascular (CV) death. Major adverse CV events (MACE) included MI/CV death, hospitalization for heart failure or unstable angina, and late unplanned coronary artery bypass graft. The prognostic association and net reclassification improvement by ischemia for MI/CV death were determined.Out of 755 patients (age 64 ± 11 years, 64% male), we observed 97 MI/CV deaths and 210 MACE over a median follow-up of 5.3 years. Presence of ischemia demonstrated a significant association with MI/CV death (HR: 2.30; 95% CI: 1.54-3.44; P 0.001) and MACE (HR: 2.24 ([95% CI: 1.69-2.95; P0.001). In a multivariate model adjusted for CV risk factors, ischemia maintained strong association with MI/CV death (HR: 1.84; 95% CI: 1.17-2.88; P = 0.008) and MACE (HR: 1.77; 95% CI: 1.31-2.40; P 0.001) and reclassified 95% of patients at intermediate pretest risk (62% to low risk, 33% to high risk) with corresponding changes in the observed event rates of 1.4% and 5.3% per year for low and high post-test risk, respectively.In a multicenter cohort of patients with known CAD, CMR-assessed ischemia was strongly associated with MI/CV death and reclassified patient risk beyond CV risk factors, especially in those considered to be at intermediate risk. Absence of ischemia was associated with a2% annual rate of MI/CV death. (Stress CMR Perfusion Imaging in the United States [SPINS] Study; NCT03192891).

Details

ISSN :
1936878X
Volume :
15
Database :
OpenAIRE
Journal :
JACC: Cardiovascular Imaging
Accession number :
edsair.doi.dedup.....d912438eae6b04e8f2890e0140480223
Full Text :
https://doi.org/10.1016/j.jcmg.2021.06.025